Holen Sie sich die Stockscreener-App
2.35
4.47%
-0.11
Handel nachbörslich:
2.35
Schlusskurs vom Vortag:
$2.46
Offen:
$2.46
24-Stunden-Volumen:
452.12K
Relative Volume:
0.45
Marktkapitalisierung:
$332.63M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-35.47M
KGV:
-4.1228
EPS:
-0.57
Netto-Cashflow:
$-124.27M
1W Leistung:
+5.38%
1M Leistung:
+35.84%
6M Leistung:
+4.44%
1J Leistung:
+125.96%
1-Tages-Spanne:
$2.32
$2.50
1-Wochen-Bereich:
$2.15
$2.545
52-Wochen-Spanne:
$0.4603
$7.13
Prokidney Corp Stock (PROK) Company Profile
Firmenname
Prokidney Corp
Sektor
Branche
Telefon
336-999-7028
Adresse
2000 FRONTIS PLAZA BLVD., WINSTON-SALEM
Compare PROK vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PROK
Prokidney Corp
|
2.35 | 348.20M | 0 | -35.47M | -124.27M | -0.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Prokidney Corp Stock (PROK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-06-30 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-09-30 | Eingeleitet | JP Morgan | Neutral |
| 2024-09-10 | Eingeleitet | Guggenheim | Buy |
| 2024-03-07 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-01-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-07-25 | Eingeleitet | BTIG Research | Buy |
| 2022-12-21 | Eingeleitet | Jefferies | Buy |
| 2022-11-10 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-10-18 | Eingeleitet | UBS | Buy |
| 2022-10-14 | Eingeleitet | Citigroup | Buy |
| 2022-09-23 | Eingeleitet | BofA Securities | Buy |
| 2022-09-02 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Prokidney Corp Aktie (PROK) Neueste Nachrichten
ProKidney (NASDAQ:PROK) Stock Price Up 9%Here's Why - MarketBeat
PROKIDNEY CORP. (PROK) CFO awarded 600,000-share stock option grant - Stock Titan
ProKidney (NASDAQ: PROK) awards 400,000 stock options to Chief Regulatory Officer - Stock Titan
ProKidney (PROK) grants CLO Todd Girolamo 600,000 stock options - Stock Titan
ProKidney (NASDAQ: PROK) CEO awarded stock options on 3,000,000 shares - Stock Titan
PROK Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
PROK Should I Buy - Intellectia AI
ProKidney Corp. (NASDAQ:PROK) Given Average Rating of "Hold" by Analysts - MarketBeat
Forecast Cut: Is ProKidney Corp impacted by rising ratesPortfolio Update Report & Verified Short-Term Plans - baoquankhu1.vn
Moving Averages: Should value investors consider ProKidney CorpJuly 2025 Short Interest & Reliable Trade Execution Plans - baoquankhu1.vn
How ProKidney Corp. stock reacts to job market dataGDP Growth & Technical Pattern Based Signals - mfd.ru
CEO Change: Whats the outlook for ProKidney Corps sectorJuly 2025 Analyst Calls & Intraday High Probability Alerts - baoquankhu1.vn
What’s the outlook for ProKidney Corp.’s sectorWeekly Risk Report & Fast Gain Swing Alerts - mfd.ru
ProKidney Corp (PROK) Touts Reparencel Therapy for Growth - MSN
Why is ProKidney Corp. stock going downWeekly Stock Recap & Intraday High Probability Alerts - mfd.ru
Can ProKidney Corp. continue delivering strong returnsJuly 2025 Earnings & Verified Chart Pattern Signals - mfd.ru
Morgan Stanley discloses 6% ProKidney (PROK) stake in Schedule 13G - Stock Titan
3 Promising Penny Stocks With At Least $600M Market Cap - simplywall.st
Will ProKidney Corp. benefit from seasonalityMarket Activity Summary & High Conviction Trade Alerts - mfd.ru
Can ProKidney Corp. be the next market leader2025 Earnings Impact & Advanced Swing Trade Entry Alerts - mfd.ru
Will ProKidney Corp. benefit from green energy policiesWeekly Trading Summary & Reliable Breakout Stock Forecasts - mfd.ru
Is ProKidney Corp. stock a top performer YTDInflation Watch & Free Reliable Trade Execution Plans - mfd.ru
Here's Why We're Watching ProKidney's (NASDAQ:PROK) Cash Burn Situation - 富途牛牛
Revenue Check: Will ProKidney Corp benefit from geopolitical trendsBreakout Watch & Weekly High Return Forecasts - baoquankhu1.vn
Will ProKidney Corp. stock keep outperforming rivalsJuly 2025 Price Swings & Fast Moving Market Watchlists - mfd.ru
ProKidney Corp Explodes Into the Spotlight: Breakthrough Stock or Overhyped Trap? - AD HOC NEWS
Layoff Watch: Does ProKidney Corp offer margin of safety2025 Buyback Activity & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
HC Wainwright Forecasts ProKidney FY2030 Earnings - MarketBeat
Growth Value: Will CVCO benefit from sector rotationJuly 2025 WrapUp & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
Is ProKidney Corp stock undervalued right nowMarket Growth Review & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
ProKidney Shares Soar After Citi Lifts Price Target to $9 - MSN
ProKidney: Preserved Long-Term Opportunity but Heightened Timeline Risk Supports Continued Hold Rating - TipRanks
ProKidney Expands Phase 3 REGEN-006 Trial Enrollment Plans - TipRanks
ProKidney CorpTopline data readout of surrogate endpoint expected Q2 2027 - marketscreener.com
Prokidney CorpTopline Data Readout Of Surrogate Endpoint Expected Q2 2027 - TradingView
ProKidney Stock: Differentiated CKD Approach Positions Rilparencel Favorably (NASDAQ:PROK) - Seeking Alpha
ProKidney Corp. (NASDAQ:PROK) Receives Average Rating of "Hold" from Analysts - MarketBeat
Macro Review: Can CBTJ expand its profit margins2025 Volatility Report & Consistent Growth Equity Picks - baoquankhu1.vn
Aug Action: Can ProKidney Corp be the next market leaderTreasury Yields & Stock Portfolio Risk Management - baoquankhu1.vn
Ideas Watch: Should I buy ProKidney Corp stock nowTrade Performance Summary & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Profit Review: Does ProKidney Corp outperform in volatile marketsTrade Entry Report & Technical Entry and Exit Alerts - baoquankhu1.vn
Investment Review: Does ProKidney Corp offer margin of safety2025 Support & Resistance & Risk Controlled Daily Trade Plans - baoquankhu1.vn
PROKProKidney Latest Stock News & Market Updates - Stock Titan
ProKidney (NASDAQ:PROK) Stock Price Down 5.5%What's Next? - MarketBeat
Risk Recap: Why is ProKidney Corp stock going downPortfolio Update Report & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Bear Alert: Why is ProKidney Corp stock going downCPI Data & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
H.C. Wainwright Maintains ProKidney(PROK.US) With Buy Rating, Maintains Target Price $12 - 富途牛牛
PROK: Pivotal phase III trial of rilparencel for advanced CKD targets Q2 2027 readout, with strong phase II results - TradingView
Recap Report: What is the cash position of ProKidney CorpBuy Signal & Free High Return Stock Watch Alerts - baoquankhu1.vn
ProKidney Advances Rilparencel Program and Manufacturing Expansion - TipRanks
ProKidney Corp Updates on Rilparencel and Phase 3 Trials - TradingView
Finanzdaten der Prokidney Corp-Aktie (PROK)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.69%
0.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):